SLC7A5 and inflammatory bowel disease: As shown in Fig. 1, high frequency of CD98+ Eos was observed in the IBD intestinal mucosa; Gal-3 is the ligand of CD98 [12], we inferred that the interaction of Gal-3 and CD98 might activate Eos.